These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7191260)

  • 21. [Biopharmaceutic investigations with D-norpseudoephedrine. 2nd communication: Bioavaliability of a depot preparation (author's transl)].
    Frosch F
    Arzneimittelforschung; 1977; 27(5):1076-8. PubMed ID: 577875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
    Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
    Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and relative bioavailability of nimodipine capsules and tablets in 8 Chinese healthy men.
    Guo LQ; Tan HS; Chen G
    Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):295-7. PubMed ID: 8249618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic profile of a slow-release ketoprofen preparation].
    Flouvat B; Stheneur A; Massias P
    Sem Hop; 1983 Dec; 59(46):3187-90. PubMed ID: 6318337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative absorption of disopyramide as determined by liquid chromatography following acute administration of standard capsules and controlled-release tablets.
    Graffner C; Lagerström PO; Lundborg PN; Rönn OF
    Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):414-9. PubMed ID: 7298249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic evaluation of two ibuprofen-codeine combinations.
    Kaltenbach ML; Mohammed SS; Mullersman G; Perrin JH; Derendorf H
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):210-4. PubMed ID: 8032582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
    Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of an extended-release theophylline product in cats.
    Guenther-Yenke CL; McKiernan BC; Papich MG; Powell E
    J Am Vet Med Assoc; 2007 Sep; 231(6):900-6. PubMed ID: 17867974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules.
    Nikolova Z; Peng B; Hubert M; Sieberling M; Keller U; Ho YY; Schran H; Capdeville R
    Cancer Chemother Pharmacol; 2004 May; 53(5):433-8. PubMed ID: 15132131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on the pharmacokinetic equivalence of pivampicillin base and hydrochloride in capsules and tablets (author's transl)].
    Fedorcak V; Mielenz H; Bozler G
    Arzneimittelforschung; 1977; 27(3):659-65. PubMed ID: 577441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relative bioavailability and pharmacokinetics of chloral hydrate and its metabolites].
    Zimmermann T; Wehling M; Schulz HU
    Arzneimittelforschung; 1998 Jan; 48(1):5-12. PubMed ID: 9522024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation of peroral delayed-action drug forms using biological polymers as the base. 4. Preparation of erosion tablets with a base of starch hydrolysis products].
    Mank R; Kala H; Lorenz A
    Pharmazie; 1989 Sep; 44(9):617-8. PubMed ID: 2608707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bioavailability of metoclopramide with special reference to relevant literature data].
    Berner G; Emschermann B; Gladtke E; Haase W; Leuschner F; Vögtle-Junkert U; Wagener HH
    Arzneimittelforschung; 1982; 32(2):169-73. PubMed ID: 7199924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability of Lynestrenol.
    Shrimanker K; Akpoviroro J; Fotherby K; Watson J
    Arzneimittelforschung; 1980; 30(3):500-2. PubMed ID: 7387763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of prazosin administered as gastro-intestinal-therapeutic-systems to 24 healthy volunteers.
    Fourtillan JB; Brisson AM; Couet W
    Therapie; 1993; 48(2):115-8. PubMed ID: 8351678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.
    Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E
    Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.